Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Atorvastatin recalled?

Yes — there is an active recall. 8 ongoing FDA recalls mention Atorvastatin (67 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Atorvastatin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Atorvastatin recalls on record

none so far in 2026; 67 on record, newest first
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.

Terminated Particulate / foreign matter Ranbaxy Inc. NDC 63304-827-90 D-1086-2014
Class II · Moderate risk

Atorvastatin Calcium

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 11845014882, Pedigree: AD70700_7, EXP: 5/29/2014; TACROLIMUS, Capsule, 0.5 mg, NDC 00781210201, Pedigree: W003169, EXP: 6/13/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD42584_1, EXP: 5/14/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-903-2014
Class II · Moderate risk

Atorvastatin Calcium

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs: ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: AD33897_4, EXP: 5/9/2014; FINASTERIDE, Tablet, 5 mg, NDC 16714052201, Pedigree: W003031, EXP: 2/28/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-902-2014
Class II · Moderate risk

Atorvastatin Calcium

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs: COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD32325_4, EXP: 5/9/2014; ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: AD49582_7, EXP: 5/16/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-901-2014
Class II · Moderate risk

Atorvastatin Calcium

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: AD30180_4, EXP: 5/8/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD49399_4, EXP: 5/16/2014; ASPIRIN, CHEW Tablet, 81 mg, NDC 00536329736, Pedi

Terminated Labeling / mix-up Aidapak Services, LLC D-900-2014
Class II · Moderate risk

Atorvastatin Calcium

Labeling:Label Mixup; ATORVASTATIN CALCIUM, Tablet, 80 mg may be potentially mislabeled as LACTOBACILLUS GG, Capsule, 10 Billion Cells, NDC 49100036374, Pedigree: AD21965_19, EXP: 5/1/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-662-2014
Class II · Moderate risk

ATORVASTATIN CALCIUM Tablet

Labeling:Label Mixup; ATORVASTATIN CALCIUM Tablet, 20 mg may be potentially mislabeled as guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003850, EXP: 6/27/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-661-2014
Class II · Moderate risk

Atorvastatin Calcium Tablets

Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.

Terminated Particulate / foreign matter Ranbaxy Inc. NDC 63304-827-90 D-060-2013
Class II · Moderate risk

Lipitor (Atorvastatin calcium)

Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.

Terminated Chemical / undeclared Physicians Total Care, Inc. NDC 54868-4229-0 D-1389-2012